KTTA (Pasithea) Earnings per share increase in current year

Corporate emblem and logo of Pasithea Therapeutics Corp. (KTTA)

Neurodrug production capacities are utilized according to clinical plans, and equipment is undergoing sterilization. Molecule synthesis and testing have been fully outsourced to external contractors. EPS YoY volatility demonstrates profit dynamics, where the value of 73.50 expresses the metric level. Pasithea Therapeutics (KTTA) is developing targeted depression therapy in US and UK centers, leveraging active research.

Earnings growth in current year: Pasithea Therapeutics Corp. (KTTA) for 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for pasitheaclinics.com (KTTA)

- business market valuation indicators:
Fundamental valuation:Pasithea Therapeutics (KTTA)
Manufactured products of Pasithea Therapeutics

For Pasithea Therapeutics (KTTA), which balances clinical trials with the operational business of ketamine centers, this indicator serves as a measure of the effectiveness of this diversification. The metric calculates the percentage deviation of current earnings per share from the same value last year, isolating the fundamental trend from market volatility. By analyzing the annual evolution of earnings per share, an investor can assess how successfully Pasithea Therapeutics converts scientific developments into real financial growth.

Direct competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|ATHA (Athira) - Earnings per share increase in current year|Addex Therapeutics - Net earnings per share growth this year|ALZN - Net earnings per share growth this year|Cyclerion Therapeutics, Inc. - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics, Inc.)|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE